G Medical Innovations Holdings Ltd
GMVD · NASDAQ
12/31/2022 | 6/30/2022 | 12/31/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | – | – | -$0 | $0 |
| % Growth | – | – | -102.5% | – |
| Gross Profit | – | – | -$0 | $0 |
| % Margin | – | – | 1,111.1% | 56.5% |
| EBITDA | – | – | $0 | -$0 |
| % Margin | – | – | -9,628.3% | -412.5% |
| Net Income | – | – | $0 | -$0 |
| % Margin | – | – | -13,308.7% | -616.4% |
| EPS Diluted | – | – | 1.61 | -47.5 |
| % Growth | – | – | 103.4% | – |
| Operating Cash Flow | – | – | -$0 | $0 |
| Capital Expenditures | – | – | -$0 | $0 |
| Free Cash Flow | – | – | -$0 | $0 |